These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16249356)

  • 1. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.
    Barrett-Lee P; Bokemeyer C; Gascón P; Nortier JW; Schneider M; Schrijvers D; Van Belle S;
    Oncologist; 2005 Oct; 10(9):743-57. PubMed ID: 16249356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
    Kosmidis P; Krzakowski M;
    Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.
    Ludwig H; Van Belle S; Barrett-Lee P; Birgegård G; Bokemeyer C; Gascón P; Kosmidis P; Krzakowski M; Nortier J; Olmi P; Schneider M; Schrijvers D
    Eur J Cancer; 2004 Oct; 40(15):2293-306. PubMed ID: 15454256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer anemia survey in Division of Medical Oncology at Siriraj Hospital (CAS).
    Ithimakin S; Srimuninnimit V
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S110-8. PubMed ID: 19562994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
    Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
    J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European Cancer Anaemia Survey.
    Barrett-Lee PJ; Ludwig H; Birgegård G; Bokemeyer C; Gascón P; Kosmidis PA; Krzakowski M; Nortier JW; Kongable G; Schneider M; Schrijvers D; Van Belle SJ;
    Oncology; 2006; 70(1):34-48. PubMed ID: 16493206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and management of anemia in renal transplantation: an observational-French study].
    Choukroun G; Deray G; Glotz D; Lebranchu Y; Dussol B; Bourbigot B; Lefrançois N; Cassuto-Viguier E; Toupance O; Hacen C; Lang P; Mazouz H; Martinez F
    Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey.
    Repetto L;
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):170-9. PubMed ID: 19406660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and incidence of anemia in Thai patients with gynecologic cancer.
    Achariyapota V; Benjapibal M; Chaopotong P
    Asian Pac J Cancer Prev; 2010; 11(5):1229-33. PubMed ID: 21198268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
    Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of anemia in long-term care (SALT): prevalence of anemia and its relationship with the risk of falls in nursing home residents.
    Pandya N; Bookhart B; Mody SH; Funk Orsini PA; Reardon G
    Curr Med Res Opin; 2008 Aug; 24(8):2139-49. PubMed ID: 18561876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-related anemia: pathogenesis, prevalence and treatment.
    Birgegård G; Aapro MS; Bokemeyer C; Dicato M; Drings P; Hornedo J; Krzakowski M; Ludwig H; Pecorelli S; Schmoll H; Schneider M; Schrijvers D; Shasha D; Van Belle S
    Oncology; 2005; 68 Suppl 1():3-11. PubMed ID: 15855811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity, risk factors, and physician practices in the management of anemia during concurrent chemoradiation for head and neck carcinoma.
    Tanvetyanon T; Choudhury AM
    Cancer; 2006 Apr; 106(7):1554-9. PubMed ID: 16518817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intervention with epoetin beta prevents severe anaemia in lung cancer patients receiving platinum-based chemotherapy: a subgroup analysis of the NeoPrevent study.
    de Castro J; Belda-Iniesta C; Isla D; Dómine M; Sánchez A; Batiste E; Barón MG
    Lung Cancer; 2008 Feb; 59(2):211-8. PubMed ID: 17875340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
    J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
    Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.